How many clinical trials are there for Engraftment Syndrome?

PlainTrial tracks 1 US clinical trials for Engraftment Syndrome, of which 1 are currently recruiting.

Which interventions appear most often on Engraftment Syndrome trial records?

Budesonide is the most-linked intervention name on Engraftment Syndrome records (1 trial links). Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for Engraftment Syndrome?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Engraftment Syndrome: later-stage trial registry

Compiled by PlainTrial · August 8, 2026

1 of 1 indexed Engraftment Syndrome trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Engraftment Syndrome: 1 US clinical trial tracked, 1 recruiting.

Engraftment Syndrome is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Henry Ford Health System, running 1 of these trials.

Enrollment posture brief

Registry condition engraftment-syndrome

Volume-matched condition peers

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Open-enrollment share among volume-matched conditions near Engraftment Syndrome

Engraftment Syndrome lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Engraftment Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

Engraftment Syndrome is recruiting above its size-band peers.

1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Open and recent trials

1 total, page 1 of 1

RECRUITING Phase 3 110 participants

Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation

Henry Ford Health System

NCT05509933

Phase Distribution

Phase	Trial count
Phase 3	1

Top Sponsors

Henry Ford Health System 1 trials

Named interventions

Most-linked intervention names on Engraftment Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Budesonide Drug

1 trials

US sites by state

Facility locations filed on Engraftment Syndrome trials. A trial with sites in several states counts in each.

Michigan 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Engraftment Syndrome page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

1 Engraftment Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
Henry Ford Health System sponsors the most Engraftment Syndrome trials on record, review their full trial history before evaluating a specific study. See Henry Ford Health System's trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Engraftment Syndrome condition card totals 1 registered trials; most-linked intervention Budesonide; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.